CLP Holdings' 2023 Net Profit Surges Sevenfold
By Amanda Lee
CLP Holdings' net profit for 2023 surged sevenfold, thanks to contributions from its core businesses in Hong Kong and China and a turnaround in the fair-value related to its forward energy contracts.
Net profit jumped to 6.66 billion Hong Kong dollars ($851.2 million) in 2023 from HK$924 million in 2022, the Hong Kong-listed power company said in a filing to the Hong Kong exchange Monday. Its revenue fell to HK$87.17 billion in 2023 from HK$100.66 billion in 2022, the company said.
CLP's operating earnings before fair value movements for 2023 increased 33% to HK$10.13 billion.
The company's fair value adjustments, mainly associated with EnergyAustralia's forward energy contracts, swung to a gain of HK$2.13 billion in 2023 from a loss of HK$2.98 billion in 2022, it said.
The company also announced a fourth interim dividend payment of HK$1.21 per share, the same as the year before. That brought total dividends in 2023 to HK$3.10, unchanged from 2022.
Write to Amanda Lee at amanda.lee@wsj.com
(END) Dow Jones Newswires
February 26, 2024 00:58 ET (05:58 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks